Sponsors

Platinum Sponsors

City of Brampton

Brampton has a strong competitive position because of its diverse and resilient economic base. It has transformed its economic development approach to target high growth business sectors. Our location in the middle of the Innovation Super Corridor, and new strategic investments, like a university, will have a significant and positive impact on the regional labour force and long-term job growth in Brampton.

According to Statistics Canada, Brampton placed 7th in the country for total construction value in 2016, generating $2 billion in investment. With high growth expected to continue until 2041, the City of Brampton is in a strong position to attract investment and will remain among the countrys most active markets in the coming decades.

Brampton’s Health and Life Sciences sector averages 6 per cent growth per year and employs over 12,000 people directly and indirectly to over 800 companies. Brampton is located in North America’s 3rd largest biotechnology cluster. Its diverse population makes it attractive to health research businesses across the world.​​​​​​​​​​​​​​​​​​

Several of the diverse national and global firms located in Brampton include:  Medtronic, Dynacare, Taro Pharmaceuticals, Stevens Co., Canadian Blood Services, Canon, William Osler Health System.

Innovative Medicines Canada

Innovative Medicines Canada represents Canada’s innovative pharmaceutical industry. We help our members discover, develop, and deliver innovative medicines and vaccines. Our membership consists of more than 50 companies, from established organizations to fledgling startups, all of whom are revolutionizing healthcare through the discovery and development of new medicines and vaccines. Guided by a strict Code of Ethical Practices, we work with governments, insurance companies, healthcare professionals and stakeholders to advance the field and enhance the wellbeing of Canadians. We are committed to being valued partners in Canada’s healthcare system. We aim to achieve these goals by forming effective alliances and supporting policies, improving Canada’s regulatory environment, widen access to innovative medicines and protect intellectual property. We believe in ensuring that Canadians have access to the innovative treatments they need and that our activities are a fundamental part of safeguarding our healthcare system for future generations. Our work allows our members to focus on what matters: delivering better healthcare solutions to Canadians.

Sanofi Pasteur

Sanofi Pasteur, the vaccines division of Sanofi, is the largest company in the world devoted entirely to human vaccines. Our driving goal is to protect people from infectious diseases by creating safe and effective vaccines. Our company offers the broadest range of vaccines in the world, providing protection against 20 bacterial and viral diseases. We distribute more than 1.6 billion doses of vaccine each year, making it possible to vaccinate more than 500 million people across the globe.

Alexion Pharma Canada

Alexion is focused on providing innovative treatments to patients with severe and life-threatening rare diseases for which there are few, if any, effective treatment options. In 2009, Alexion began operations in Canada to serve patients locally. We aim to work in partnership with all stakeholders including healthcare providers, patient advocacy organizations and government in order to best serve patients. By expanding the knowledge and awareness of rare diseases, we help the medical community improve the process for diagnosis and treatment. Our goal is to bring hope to patients and families by delivering life-changing therapies.

In Canada, Soliris® has received marketing authorization from Health Canada for all patients with PNH. Soliris® is also approved by Health Canada as safe and effective for use in children and adults with atypical HUS to inhibit complement-mediated thrombotic microangiopathy (TMA). To further advance the understanding of PNH and atypical HUS in the Canadian population, Alexion Canada sponsors disease registries that enroll treated and untreated patients who are diagnosed with these conditions. This is our commitment to ongoing research into the rare conditions that our therapies treat.

Learn more about Alexion’s research and development efforts.

Horizon Therapeutics Canada

Horizon Therapeutics Canada is a wholly owned subsidiary of Horizon Pharma plc, a biopharmaceutical company focused on improving patients’ lives by developing and commercializing differentiated and accessible medicines that address unmet medical needs in the fields of rare diseases, rheumatology and primary care.  Founded in 2008 as a small start-up, Horizon has evolved in less than a decade into a global biopharmaceutical company active in several important therapeutic fields.

Taiho Pharma Canada Inc.

Taiho Pharma Canada, Inc., a Canadian subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), is located in Oakville, Ontario and managed by Taiho Oncology based in Princeton, New Jersey. Taiho Pharma’s mission in Canada is to lead oncology innovation, drive research and transform the lives of Canadians living with cancer.  Taiho Oncology has established world class clinical development and commercial organizations that work urgently to develop and market innovative cancer treatments.  Taiho Oncology Inc. has an oral oncology pipeline consisting of both novel anti-metabolic agents and selectively targeted agents. Advanced technology, dedicated researchers, and state of the art facilities are helping Taiho define the way the world treats cancer. It’s our work; it’s our passion; it’s our legacy.

Silver Sponsors

BDO Canada

BDO Canada has spent more than 90 years providing assurance, accounting, tax, and advisory services to a broad range of clients across the country. And as a member firm of the international BDO network, we leverage access to resources and advisors in more than 150 countries around the world.

Founded in 1921, we have grown from a single office in Winnipeg to more than 3,000 partners and professionals in over 100 offices across Canada. Yet our strengths remain firmly rooted in the communities we serve.

At BDO, we aim to create a collaborative working environment that makes it possible for our professionals and clients to achieve their goals. We always begin at the local, individual level, delivering highly personalized guidance, industry-specific knowledge, and unparalleled service to exceed the expectations of every client – public or private, big or small. And as our team and our clients’ needs expand globally, we draw on our resources around the world.

Ernst & Young LLP

At EY, we are committed to building a better working world — with increased trust and confidence in business, sustainable growth, development of talent in all its forms, and greater collaboration. We want to build a better working world through our own actions and by engaging with like-minded organizations and individuals. This is our purpose — and why we exist as an organization. Running through our organization is a strong sense of obligation to serve a number of different stakeholders who count on us to deliver quality and excellence in everything we do. We want to use our global reach and scale to convene the conversation about the challenges facing economies and the capital markets. When business works better, the world works better. Learn more about our commitment to building a better working world.

Richmond Hill

Numerous objective rankings from around the world name Richmond Hill as a top Canadian business destination. Richmond Hill has an enviable pool of immensely talented, well educated people, a diverse and resilient local economy, and a business base known for perseverance, innovation and entrepreneurial spirit. With exceptional transportation links, the most educated workforce in Canada, an economic development team eager to support you and a diverse and welcoming community, Richmond Hill is the smart place for business.